Coronary Bifurcation Stenting (COBIS) Registry in South Korea

Completed

• Conditions: Coronary Bifurcation Lesion

• Registration Number: NCT00851526
• Lead Sponsor: Samsung Medical Center

Brief Summary

The COBIS registry is multi-center, real-world registry of drug-eluting stenting in coronary bifurcation lesions in South Korea.

The aim of the study was to find out the current status of bifurcation drug-eluting stenting and determine the prognostic factors for long-term outcome in South Korea.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-01
• Primary Completion: 2008-12
• Study Completion: 2008-12
• Study First Submitted: 2009-02-25
• Study First Submitted QC: 2009-02-25
• Study First Posted: 2009-02-26
• Status Verified: 2012-07
• Last Update Submitted: 2012-07-15
• Last Update Posted: 2012-07-17

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 1919

Inclusion Criteria

• Age >= 18 years
• Any type of de novo bifurcation lesion with a parent vessel >= 2.5 mm and side branch>= 2.0 mm by visual estimation
• Treated with drug-eluting stent

Exclusion Criteria

• Cardiogenic Shock
• ST elevation MI within 48hours
• Expected survival less than 1 year
• Left main bifurcation
• Allergy to the antiplatelets

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of the composite outcome of all-cause death, MI, or any PCI/CABG	3 years

Secondary Outcome Measures

Name	Time	Method
Incidence of stent thrombosis, and periprocedural MI	3 years

Trial Locations

Locations (1)

Samsung Medical Center; 🇰🇷 Seoul, Korea, Republic of